Marta Kozaric
Overview
Explore the profile of Marta Kozaric including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horgan D, Van Den Bulcke M, Malapelle U, Normanno N, Capoluongo E, Prelaj A, et al.
Curr Oncol
. 2024 Apr;
31(4):1839-1864.
PMID: 38668042
Understanding the diversity in cancer research priorities and the correlations among different treatment modalities is essential to address the evolving landscape of oncology. This study, conducted in collaboration with the...
2.
Horgan D, Van Den Bulcke M, Malapelle U, Normanno N, Capoluongo E, Prelaj A, et al.
Healthcare (Basel)
. 2024 Jan;
12(2).
PMID: 38275541
Improvements in cancer care require a new degree of collaboration beyond the purely medical sphere, extending deeply into the world of other stakeholders-preeminently patients but also the other stakeholders in...
3.
Horgan D, Van Den Bulcke M, Malapelle U, Troncone G, Normanno N, Capoluongo E, et al.
Heliyon
. 2024 Jan;
10(1):e23914.
PMID: 38234913
Next-generation sequencing (NGS) and liquid biopsy (LB) showed positive results in the fight against different cancer types. This paper aims to assess the uptake of advanced molecular diagnostics/NGS for quick...
4.
Horgan D, Hamdi Y, Lal J, Nyawira T, Meyer S, Kondji D, et al.
Healthcare (Basel)
. 2023 Feb;
11(3).
PMID: 36767006
Radical new possibilities of improved treatment of cancer are on offer from an advanced medical technology already demonstrating its significance: next-generation sequencing (NGS). This refined testing provides unprecedentedly precise diagnoses...
5.
Horgan D, Hamdi Y, Lal J, Nyawira T, Meyer S, Kondji D, et al.
Diagnosis (Berl)
. 2022 Dec;
10(2):140-157.
PMID: 36548810
Objectives: The introduction of Personalised Medicine (PM) into healthcare systems could benefit from a clearer understanding of the distinct national and regional frameworks around the world. Recent engagement by international...
6.
Horgan D, Plebani M, Orth M, Macintyre E, Jackson S, Lal J, et al.
Clin Chem Lab Med
. 2022 Nov;
61(2):224-233.
PMID: 36409605
The background to this debate is now well-known: an EU policy decision to tighten controls on the devices and diagnostics sector led to the adoption of a regulation in 2017...
7.
Horgan D, Mia R, Erhabor T, Hamdi Y, Dandara C, Lal J, et al.
Healthcare (Basel)
. 2022 Nov;
10(11).
PMID: 36360466
Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same...
8.
Horgan D, Cufer T, Gatto F, Lugowska I, Verbanac D, Carvalho A, et al.
Healthcare (Basel)
. 2022 Sep;
10(9).
PMID: 36141326
Liquid biopsy (LB) is a minimally invasive method which aims to detect circulating tumor-derived components in body fluids. It provides an alternative to current cancer screening methods that use tissue...
9.
Horgan D, Walewski J, Aurer I, Visco C, Gine E, Fetica B, et al.
Healthcare (Basel)
. 2022 Sep;
10(9).
PMID: 36141294
An expert panel convened by the European Alliance for Personalized Medicine (EAPM) reflected on achievements and outstanding challenges in Europe in mantle cell lymphoma (MCL). Through the prism of member...
10.
Horgan D, Hajduch M, Vrana M, Soderberg J, Hughes N, Omar M, et al.
Healthcare (Basel)
. 2022 Sep;
10(9).
PMID: 36141241
The May 2022 proposal from the European commission for a 'European health data space' envisages advantages for health from exploiting the growing mass of health data in Europe. However, key...